Monika Rai

Monika Rai

Monika practices in the life sciences field, with a particular focus on diagnostics, biopharmaceuticals and biologics. Monika is a European Patent Attorney and a Chartered Patent Attorney.  She also qualified as a Solicitor (England & Wales) and holds a Higher Courts Litigation Certificate providing enhanced rights to conduct IP litigation in the UK courts. She joined Mathys & Squire in 2014 after several years in private practice in India and the UK and a year spent as a consultant with a global healthcare company.

Monika Rai


Year joined:2014

Qualifications:BSc LLB LLM EPA CPA


Monika has substantial experience of contentious proceedings at the European Patent Office and has successfully represented clients at several opposition hearings. She has also coordinated and advised on major IP due diligence projects involving analysis of freedom to operate issues and contractual IP provisions. She advises a varied client base on patent prosecution and contentious matters in a range of technical areas, including diagnostic assays, therapeutic nucleotides and peptides, antibody formats, antibody discovery, stem cells, microbiome therapy products and inhaled small molecule formulations. This breadth of experience enables her to tailor her approach to suit client needs. Monika also contributes to training by being involved as an examiner on a Litigation Skills Course for newly qualified patent attorneys.


Monika has a first class bachelor of science in botany honours and a law degree, both from the University of Delhi. She then attended the London School of Economics and Political Science from where she gained a master of laws degree, specialising in intellectual property.

Membership & Organisations

Monika is a member of European Patent Institute and a fellow of The Chartered Institute of Patent Attorneys.

Sectors & Specialisms

Monika works with clients in the following sectors:
Biotechnology, life sciences

Monika specialises in: 
Patent applications, patent drafting and filing, freedom to operate, due diligence, patent enforcement, IP strategy, patent portfolio management, licensing, patent oppositions, commercialisation

Follow us on twitter